3 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 9 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 3, Unknown 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Iron-deficiency: new trials by email Literature Review of Iron-deficiency trials Research Report on Iron-deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma Iron Isomaltoside 1000, Polysaccharide Iron Complex Pill, Intensity-modulated radiotherapy - Nasopharyngeal Carcinoma, Iron-deficiency | Phase 2 | Unknown | Sun Yat-sen University | 120 | 2023-05-05 | 2023-06-22 |
| Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants Darbepoetin Alfa, Low Molecular Weight Iron Dextran, Ferumoxytol injection - Prematurity, Iron-deficiency | Phase 2 | Recruiting | University of Washington | 120 | 2022-11-27 | 2026-05-26 |
| Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer Iron(III)isomaltoside, Placebo - Iron-deficiency, Colorectal Cancer | Phase 2 | Not yet recruiting | Zealand University Hospital | 134 | 2022-03-01 | 2022-03-03 |
| Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF) Ferric Derisomaltose 1000 Mg in 100 mL INTRAVENOUS SOLUTION [Monoferric], Placebo - Iron-deficiency, Heart Failure With Preserved Ejection Fraction | Phase 2 / Phase 3 | Completed | Massachusetts General Hospital | 65 | 2021-11-26 | 2026-09-04 |
| Iron Sucrose in Patients With Iron Deficiency and POTS Sucrose, Placebo, Tilt Table Test - Iron-deficiency, Postural Orthostatic Tachycardia Syndrome | Phase 2 | Withdrawn | Mayo Clinic | 2021-04-01 | 2023-06-13 | |
| Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis Intravenous iron isomaltoside, Placebo - Severe Aortic Stenosis, Iron-deficiency | Phase 2 | Completed | Oslo University Hospital | 149 | 2020-01-13 | 2026-04-15 |
| Probing the Synergistic Effect of Pre-Biotics & Iron Fortificants in Anemic Subjects Prebiotic + Iron Forificant - Iron-deficiency | Phase 1 / Phase 2 | Completed | University of Veterinary and Animal Sciences, Lahore - Pakistan | 75 | 2019-04-06 | 2019-08-22 |
| Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) Ferrous succinate - Vascular Cognitive Impairment, Dementia, Vascular | Phase 2 | Unknown | Beijing Tiantan Hospital | 1006 | 2019-04-01 | 2020-07-13 |
| Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency Ferric Carboxymaltose, Placebo, 31P MRS/MRI - Iron-deficiency | Phase 2 | Terminated | NYU Langone Health | 20 | 2017-09-07 | 2023-07-05 |
Anemia, Iron-Deficiency (9) · Iron Deficiencies (3) · Anemia (2) · Aortic Valve Stenosis (1) · Cerebral Infarction (1) · Colorectal Neoplasms (1) · Dementia (1) · Dementia, Vascular (1) · Nasopharyngeal Carcinoma (1) · Postural Orthostatic Tachycardia Syndrome (1) · Premature Birth (1)
Anemia, Hypochromic (9) · Hematologic Diseases (9) · Hemic and Lymphatic Diseases (9) · Iron Metabolism Disorders (9) · Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Anemia (7) · Iron Deficiencies (6) · Cardiovascular Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Nervous System Diseases (2) · Aortic Valve Disease (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1)
Darbepoetin alfa (1) · Ferric Oxide, Saccharated (1) · Ferrosoferric Oxide (1) · Iron-Dextran Complex (1) · Niferex (1) · Prebiotics (1) · Radiotherapy, Intensity-Modulated (1) · Saline Solution (1) · Sodium Chloride (1) · Sucrose (1) · Tilt-Table Test (1) · ferric carboxymaltose (1) · ferric derisomaltose (1) · ferrous succinate (1) · iron isomaltoside 1000 (1)
Beijing Tiantan Hospital (1) · Massachusetts General Hospital (1) · Mayo Clinic (1) · NYU Langone Health (1) · Oslo University Hospital (1) · Sun Yat-sen University (1) · University of Veterinary and Animal Sciences, Lahore - Pakistan (1) · University of Washington (1) · Zealand University Hospital (1)
United States (3) · China (2) · Denmark (1) · Norway (1) · Pakistan (1)
Dr. Waqas Ahmad, PhD (1) · Greg Lewis, MD (1) · Jia Qian, doctor (1) · Kamal Shouman, MD (1) · Kendell R German, MD (1) · Lars Gullestad, MD, PhD (1) · Shan Shan Guo, Dr (1) · Stuart Katz, MD (1)
PMID 35579454, PMID 36691165, PMID 38789134, PMID 41430711
2019 (1), R01HD107003 (1), R01HL151841 (1)